60 Degrees Pharmaceuticals is a pharmaceutical company focused on using biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. Co. has received regulatory approval of Arakoda, a malaria preventative treatment that is on the market. Co.'s pipeline under development covers development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir. The SXTP average annual return since 2023 is shown above.
The Average Annual Return on the SXTP average annual return since 2023 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether SXTP average annual return since 2023 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the SXTP average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|